|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/575 | (2006.01) |
| A61K 31/765 | (2006.01) | ||
| A61K 31/205 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61Q 19/06 | (2006.01) |
| (11) | Number of the document | 2422789 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11166225.0 |
| Date of filing the European patent application | 2005-02-08 | |
| (97) | Date of publication of the European application | 2012-02-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation | 2018-03-12 |
| (30) | Number | Date | Country code |
| 572879 P | 2004-05-19 | US |
| (72) |
Kolodney, Michael S., US
Rotunda, Adam M., US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 1124 West Carson Street, Torrance, CA 90502, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Injekcinės kompozicijos, apimančios natrio deoksicholiatą |
| Injectable coposition comprising sodium deoxycholate |
| Payment date | Validity (years) | Amount | |
| 2024-01-09 | 347.00 EUR |